P-D-R Pharma Documentation Ring

The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations.

Latest News from the P-D-R Company Websites

Published 27 January 2020 | 2:51 pm

GSK licenses tuberculosis vaccine candidate to the Bill & Melinda Gates Medical Research Institute for continued development The M72/AS01

Etuberculosis vaccine candidate demonstrated in a phase IIb trial the potential to reduce active pulmonary TB by half in adults with latent TB infection.[1] more ...

Published 27 January 2020 | 11:32 am

Vier Karrierevors├Ątze f├╝r 2020

Chief Human Resources Officer Elizabeth Walker gibt Tipps für die berufliche Karriere more ...

Published 27 January 2020 | 10:15 am

Investor Update

more ...

Published 27 January 2020 | 9:55 am

Perseverance in Rare Diseases

There are 7,000 known rare diseases in the world that collectively affect 350 million patients. For these patients and their families, the journey can be long and challenging. more ...

Published 27 January 2020 | 8:27 am

AstraZeneca to recover the global rights to brazikumab (MEDI2070) from Allergan

Agreement strengthens AstraZeneca's respiratory and immunology pipeline more ...

Published 27 January 2020 | 8:27 am

Phase II DESTINY-Gastric01 trial of Enhertu versus chemotherapy met primary endpoint

Trial met primary endpoint of objective response rate and key secondary endpoint of overall survival in patients with previously treated HER2-positive metastatic gastric cancer more ...

Published 27 January 2020 | 8:11 am

Brilinta met primary endpoint in Phase III THALES trial in stroke

Brilinta reduced the risk of the composite of stroke and death after an acute ischaemic stroke or transient ischaemic attack more ...

Published 27 January 2020 | 8:11 am

AstraZeneca divests rights to established hypertension medicines

Sale of Inderal, Tenormin, Tenoretic, Zestril and Zestoretic to Atnahs Pharma supports AstraZeneca's strategy of focusing on pipeline of new medicines more ...

Published 27 January 2020 | 7:25 am

Investor Update

more ...

Published 24 January 2020 | 1:20 pm

Anat Hakim to join Lilly as General Counsel

INDIANAPOLIS, Jan. 24, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that Anat Hakim will join the company on February 3, 2020 as senior more ...

Pharma Documentation Ring:
26 companies - 4 common aims:

  • Promote exchange of experience/networking among members
  • Encourage commercial development of new information services and systems
  • Jointly assess new and existing products and services
  • Provide a forum for the information industry
  • How to become a P-D-R member?
61st P-D-R Annual General Meeting, Summit, NJ, USA, September 17 - 20 2019

61st P-D-R Annual General Meeting, Summit, NJ, USA, September 17 - 20 2019